68ga-nota-rm26
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2016 (NCT03347864)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-nota-rm26
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05001204 | Early Phase 1 (Phase 1) | May 1, 2021 | Chinese Academy of Medical Sciences |
| NCT03164837 | Phase 1 | Nov 1, 2016 | National Institutes of Health (NIH), Tsinghua University |
| NCT03347864 | Early Phase 1 (Phase 1) | Oct 31, 2016 | Chinese Academy of Medical Sciences, Tsinghua University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Tsinghua University | Academic/Hospital | 2 | 1 | 1 | 2016 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1